Manipulation of this naturally homeostatic checkpoint interaction by tumors inhibits T cell-mediated tumor clearance, and therapies disrupting the PD-1/PD-L1 axis have been some of the most successful cancer treatments of the past decade.17 The gene discussed is CD274; the disease is neoplasm.